Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria A Graham

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Cytokine|October 3, 2019
Lineage-dependent differences of Zika virus infection in a susceptible mouse model are associated with different profiles of cytokines, chemokines, growth factors and acute phase proteinsStuart D Dowall, Victoria A Graham, Roger Hewson
European Journal of Immunology|March 3, 2007
A role for CD44 in T cell development and function during direct competition between CD44+ and CD44- cellsVictoria A Graham, Amanda L Marzo, David F Tough
Methods (San Diego, Calif.)|February 17, 2019
Use and reliability of multiplex bead-based assays (Luminex) at Containment Level 4Stuart D Dowall, Victoria A Graham, Tom Fletcher, et al.
Journal of Immunological Methods|June 30, 2009
Multiplex cytokine profiling with highly pathogenic material: use of formalin solution in luminex analysisStuart D Dowall, Victoria A Graham, Thomas R W Tipton, et al.
Plos Neglected Tropical Diseases|July 4, 2017
Lineage-dependent differences in the disease progression of Zika virus infection in type-I interferon receptor knockout (A129) miceStuart D Dowall, Victoria A Graham, Emma Rayner, et al.
The Journal of General Virology|July 16, 2020
Hantavirus infection in type I interferon receptor-deficient (A129) miceStuart D Dowall, Victoria A Graham, Marilyn Aram, et al.
Vaccine|November 1, 2019
Towards quantification of protective antibody responses by passive transfer of the 1st WHO International Standard for Ebola virus antibody in a guinea pig modelStuart D Dowall, Sarah Kempster, Stephen Findlay-Wilson, et al.
Plos One|June 9, 2016
Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responsesStuart D Dowall, Victoria A Graham, Emma Rayner, et al.
Viruses|March 30, 2023
Use of a Preclinical Natural Transmission Model to Study Antiviral Effects of a Carbohydrate-Binding Module Therapy against SARS-CoV-2 in HamstersDaniel Knott, Rachel Fell, Jane A Potter, et al.
Viruses|October 26, 2024
Comparison of Chikungunya Virus-Induced Disease Progression and Pathogenesis in Type-I Interferon Receptor-Deficient Mice (A129) and Two Wild-Type (129Sv/Ev and C57BL/6) Mouse StrainsVictoria A Graham, Linda Easterbrook, Emma Rayner, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cytokine|October 3, 2019
Lineage-dependent differences of Zika virus infection in a susceptible mouse model are associated with different profiles of cytokines, chemokines, growth factors and acute phase proteinsStuart D Dowall, Victoria A Graham, Roger Hewson
European Journal of Immunology|March 3, 2007
A role for CD44 in T cell development and function during direct competition between CD44+ and CD44- cellsVictoria A Graham, Amanda L Marzo, David F Tough
Methods (San Diego, Calif.)|February 17, 2019
Use and reliability of multiplex bead-based assays (Luminex) at Containment Level 4Stuart D Dowall, Victoria A Graham, Tom Fletcher, et al.
Journal of Immunological Methods|June 30, 2009
Multiplex cytokine profiling with highly pathogenic material: use of formalin solution in luminex analysisStuart D Dowall, Victoria A Graham, Thomas R W Tipton, et al.
Plos Neglected Tropical Diseases|July 4, 2017
Lineage-dependent differences in the disease progression of Zika virus infection in type-I interferon receptor knockout (A129) miceStuart D Dowall, Victoria A Graham, Emma Rayner, et al.
The Journal of General Virology|July 16, 2020
Hantavirus infection in type I interferon receptor-deficient (A129) miceStuart D Dowall, Victoria A Graham, Marilyn Aram, et al.
Vaccine|November 1, 2019
Towards quantification of protective antibody responses by passive transfer of the 1st WHO International Standard for Ebola virus antibody in a guinea pig modelStuart D Dowall, Sarah Kempster, Stephen Findlay-Wilson, et al.
Plos One|June 9, 2016
Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responsesStuart D Dowall, Victoria A Graham, Emma Rayner, et al.
Viruses|March 30, 2023
Use of a Preclinical Natural Transmission Model to Study Antiviral Effects of a Carbohydrate-Binding Module Therapy against SARS-CoV-2 in HamstersDaniel Knott, Rachel Fell, Jane A Potter, et al.
Viruses|October 26, 2024
Comparison of Chikungunya Virus-Induced Disease Progression and Pathogenesis in Type-I Interferon Receptor-Deficient Mice (A129) and Two Wild-Type (129Sv/Ev and C57BL/6) Mouse StrainsVictoria A Graham, Linda Easterbrook, Emma Rayner, et al.
Pageof 2